1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

Baron Funds Comments on Foundation Medicine Inc.

February 26, 2014 | About:

Foundation Medicine, Inc. (NASDAQ:FMI), a provider of high end genetic oncology testing and informatics, was hurt by 33% during the quarter after investors grew concerned over reimbursement for its tests. Certain competitor tests were cut substantially by CMS (which determines Medicare pricing, and which in many cases is followed by private payers). However, the competitor tests provide testing for only a handful of genes and other markers, while Foundation's tests provide for hundreds at only about twice the price. The additional markers provided in Foundation's tests allow oncologists to determine whether there might be other disease pathways at work in a patient's cancer, which allows better targeting of therapy (costing orders of magnitude more per year than the testing). We continue to believe that Foundation will establish itself as a share leader, and that it has many years of growth ahead.

From Ron Baron (Trades, Portfolio)'s Baron Funds fourth quarter 2013 letter to shareholders.

Rating: 5.0/5 (1 vote)


Please leave your comment:

Performances of the stocks mentioned by

User Generated Screeners

Bogdan BednarskiDividends Basic
daftheadersg hk best
henrikLynch inspiret Oct 17
lajor10Low EV/EBITDA
canidPE >50th percentile of INDUSTR
brucexoct 17 user defined screen
AngryQuality Growth cheap
EnjoylifeDad 1
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat